Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer 5-year disease-free and overall survival data

被引：0
|
作者：
Vriens, B. [1 ]
Aarts, M. [1 ]
Van Gastel, S. [2 ]
Van den Berkmortel, F. [3 ]
Smilde, T. [4 ]
Van Warmerdam, L. [5 ]
De Boer, M. [1 ]
Van Spronsen, D. J. [6 ]
Peer, P. [7 ]
Tjan-Heijnen, V. [1 ]
机构：
[1] Maastricht Univ, Med Ctr, Med Oncol, NL-6200 MD Maastricht, Netherlands
[2] Comprehens Canc Ctr Netherlands, Canc Registry, Nijmegen, Netherlands
[3] Zuyderland Hosp, Med Oncol, Heerlen, Netherlands
[4] Jeroen Bosch Hosp, Med Oncol, Shertogenbosch, Netherlands
[5] Catharina Hosp, Med Oncol, Eindhoven, Netherlands
[6] Canisius Wilhelmina Hosp, Med Oncol, Nijmegen, Netherlands
[7] Radboud Inst Hlth Sci, Biostat, Nijmegen, Netherlands
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
354
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [1] Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer
    Vriens, B. E. P. J.
    Aarts, M. J. B.
    de Vries, B.
    van Gastel, S. M.
    Wals, J.
    Smilde, T. J.
    van Warmerdam, L. J. C.
    de Boer, M.
    van Spronsen, D. J.
    Borm, G. F.
    Tjan-Heijnen, V. C. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (15) : 3102 - 3110
  • [2] Overall 5-year survival rate and disease-free survival after segmentectomy versus lobectomy in patients with non-small cell lung cancer
    Kadeetham, Khunthorn
    Ngodngamthaweesuk, Montien
    Kantathut, Narongrit
    Samankatiwat, Piya
    Cherntanomwong, Piya
    Leelayana, Parinya
    Khajarern, Siam
    SAGE OPEN MEDICINE, 2022, 10
  • [3] Neoadjuvant chemotherapy response, disease-free survival, and overall survival of breast cancer in a single institution
    Prihantono
    Faruk, Muhammad
    SURGERY OPEN SCIENCE, 2023, 15 : 19 - 25
  • [4] Does 5-year disease-free survival correlate with 5-year overall survival in adjuvant taxane-based chemotherapy for breast cancer? Analysis of randomized clinical trials
    Cuppone, Federica
    Bria, Emilio
    Ciccarese, Mariangela
    Nistico, Cecilia
    Carlini, Paolo
    Natoli, Guido
    Nuzzo, Carmen
    Terzoli, Edmondo
    Cognetti, Francesco
    Giannarelli, Diana
    ANNALS OF ONCOLOGY, 2006, 17 : 98 - 98
  • [5] DISEASE-FREE SURVIVAL AS A SURROGATE FOR 5-YEAR OVERALL SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA
    Cha, Eugene K.
    Fajkovic, Harun
    Rink, Michael
    Pycha, Armin
    Dunning, Allison
    Novara, Giacomo
    Karakiewicz, Pierre I.
    Margulis, Vitaly
    Raman, Jay D.
    Lotan, Yair
    Kassouf, Wassim
    Fritsche, Hans-Martin
    Bensalah, Karim
    Weizer, Alon
    Kikuchi, Eiji
    Roscigno, Marco
    Remzi, Mesut
    Matsumoto, Kazumasa
    Zigeuner, Richard
    Scherr, Douglas S.
    Mazumdar, Madhu
    Sonpavde, Guru
    Shariat, Shahrokh F.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E161 - E161
  • [6] Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival
    Talarico, Maria Cecilia Ramiro
    Derchain, Sophie
    da Silva, Lucas Ferreira
    Sforca, Mauricio L.
    Rocco, Silvana A.
    Cardoso, Marcella R.
    Sarian, Luis Otavio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [7] The effect of exercise on disease-free survival and overall survival in patients with breast cancer
    Nadiye Akdeniz
    Muhammet Ali Kaplan
    Mehmet Küçüköner
    Zuhat Urakçı
    Şahin Laçin
    Emre Hüsnü Ceylan
    Abdurrahman Işıkdoğan
    Irish Journal of Medical Science (1971 -), 2022, 191 : 1587 - 1597
  • [8] The effect of exercise on disease-free survival and overall survival in patients with breast cancer
    Akdeniz, Nadiye
    Kaplan, Muhammet Ali
    Kucukoner, Mehmet
    Urakci, Zuhat
    Lacin, Sahin
    Ceylan, Emre Husnu
    Isikdogan, Abdurrahman
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (04) : 1587 - 1597
  • [9] Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
    Dandan Yan
    Xianli Ju
    Bin Luo
    Feng Guan
    Huihua He
    Honglin Yan
    Jingping Yuan
    BMC Cancer, 22
  • [10] Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
    Yan, Dandan
    Ju, Xianli
    Luo, Bin
    Guan, Feng
    He, Huihua
    Yan, Honglin
    Yuan, Jingping
    BMC CANCER, 2022, 22 (01)
12345